DIHUA YU to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications DIHUA YU has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.037
-
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex. Nat Cancer. 2022 10; 3(10):1211-1227.
Score: 0.037